NCT06828718View on ClinicalTrials.gov

The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC）

Active, not recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Esophageal Carcinoma
Trial Locations (1)

Unknown

Shijiazhuang

All Listed Sponsors
collaborator

Tianjin Medical University Cancer Institute and Hospital

OTHER

collaborator

Fujian Cancer Hospital

OTHER_GOV

collaborator

Shandong Cancer Hospital and Institute

OTHER

collaborator

Shanxi Province Cancer Hospital

OTHER

collaborator

Jiangsu Cancer Institute & Hospital

OTHER

collaborator

Sichuan Cancer Hospital and Research Institute

OTHER

lead

Hebei Medical University Fourth Hospital

OTHER

NCT06828718 - The Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC） | Biotech Hunter | Biotech Hunter